Anticipating strong quarterly earnings for Exact Sciences, TheStreet believes the Cologuard-maker is in line for growth.
Exact Sciences Chairman, President and CEO Kevin Conroy is tackling a problem. His company’s Cologuard test is an effective colonoscopy alternative that’s being met by criticism from some gastroenterologists. Mr. Conroy spoke about the test to Forbes, which is profiling him in an upcoming issue
Lumendi‘s DiLumen EIP earned CE certification.
Slater Endoscopy‘s Monopolar Ensizor Endoscopic Scissors received FDA approval.
More articles on gastroenterology and endoscopy:
91 GI practices in the news in 2018
How the proposed 2019 Medicare Physician Fee Schedule can impact GIs — 12 insights
GI leader to know: Dr. Nicole Palekar of Cleveland Clinic Florida
